Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy

Inclusion Criteria: * Patients with newly diagnosed NAION (within the past 30 days but preferably within the first 14). Exclusion Criteria: * Patients who are unable to give informed consent * Patient with: * uncontrolled glaucoma * pregnancy * lactation * proliferative diabetic retinopathy * active clinically significant diabetic macular edema * active uveitis * prior treatment with intraocular steroids that incited significant increase in intra-ocular pressure * other known causes of decreased visual acuity in the recently involved eye such as significant dry or wet macular degeneration * previous history of other optic neuropathies * previous history of ocular trauma that resulted in decreased visual acuity * Patients with baseline amblyopia in the newly involved eye and visual acuity worse than 20/50 prior to the onset of NAION * Previous treatment for any ocular condition with any investigational drugs